Why PsyBio Will be the Leader in the Psychedelic Drug Discovery Industry:
IP Protected Bio synthetic pathway for candidate production
Ability to Manufacture and conduct invitro & invivo efficacy testing and conduct human
clinical trial psychedelic inspired compound discovery and production
Portfolio of psycho-targeted biotherapeutics manufacturing organizations for process development and commercialization of lead
compounds
PsyBio is one of a small number of companies actively working towards US FDA sanctioned clinical trials in the psychedelic inspired biotherapeutic space.
Molecular development Pipeline
